Literature DB >> 35058695

Tracer Pharmaceuticals Availability and Distribution Trends Prior to and During the Covid-19 Pandemic: A Comparative Study.

Tafesse Gizaw1, Awol Jemal2, Tadesse Gudeta2.   

Abstract

BACKGROUND: Coronavirus disease 2019 (Covid-19) has had an unprecedented impact on the health products delivery system. To maintain routine health services, tracer pharmaceuticals (TPs) should always be available and accessible in healthcare institutions. Thus, this study aimed to explore the influence of the Covid-19 on TPs availability and distribution trends in the context of the Covid-19 pandemic in Ethiopia.
METHODS: An institution-based comparative study was undertaken on 25 TPs in the pharmaceutical supply agency. From the agency's logistical data, we collated the amount of TPs ordered, received, and distributed, as well as the stock status, by using an observation checklist. The collated data were recorded in Microsoft Excel and transferred to SPSS for analysis. A frequency and percentage analysis were performed to evaluate the fill rate, product availability, and stock-out duration. A dependent t-test was used to compare if there was a significant mean difference in TPs distribution before and after the Covid-19 at a p-value less than 5%.
RESULTS: Before Covid-19, 18 (72%) of the TPs were refilled above 80% of amount ordered. After the pandemic, however, the fill rate dropped to 48%. The availability of TPs during the Covid-19 was 60%. During the six months of Covid-19, the average stock-out duration for all TPs was 34.68 days, with Cimetidine 200mg/mL injectable (line-item fill rate = 0, days out of stock = 180 days) being the most stocked-out item. Tracer pharmaceuticals distribution before Covid-19 (M = 81,317, SD = 139,274) were significantly different after the pandemic (M = 60,212, SD = 94,966) at the 5% significance level (t (24) = 2.289, p = 0.031).
CONCLUSION: This survey reveals how Covid-19 has influenced service providers' logistics systems. Following the pandemic, the line fill rate fell below half with a three-fifths availability of products. To effectively manage supply chain disruptions experienced in Covid-19 and beyond, the agency in collaboration with stakeholders should make an effort to enhance end-to-end inventory visibility, establish a resilient logistics system, strengthen domestic manufacturers' capabilities, and develop contingency plans with supplying partners.
© 2022 Gizaw et al.

Entities:  

Keywords:  Covid-19; Ethiopia; availability; distribution; pharmaceutical supply agency; tracer pharmaceutical

Year:  2022        PMID: 35058695      PMCID: PMC8765269          DOI: 10.2147/JMDH.S341855

Source DB:  PubMed          Journal:  J Multidiscip Healthc        ISSN: 1178-2390


  12 in total

1.  COVID-19 vaccines: how to ensure Africa has access.

Authors:  John N Nkengasong; Nicaise Ndembi; Akhona Tshangela; Tajudeen Raji
Journal:  Nature       Date:  2020-10       Impact factor: 49.962

2.  COVID-19 in Ethiopia: Assessment of How the Ethiopian Government has Executed Administrative Actions and Managed Risk Communications and Community Engagement.

Authors:  Mekonnen Hailemariam Zikargae
Journal:  Risk Manag Healthc Policy       Date:  2020-12-03

3.  The availability of six tracer medicines in private medicine outlets in Uganda.

Authors:  Catherine Birabwa; Jude Murison; Valerie Evans; Celestino Obua; Amon Agaba; Paul Waako; Allyson Pollock
Journal:  J Pharm Policy Pract       Date:  2014-12-08

4.  An appeal for large scale production of antiretroviral drugs in Africa.

Authors:  Nkamedjie Pete Patrick Martial; Isidore Sieleunou
Journal:  Pan Afr Med J       Date:  2016-09-21

5.  More Than Bar Codes: Integrating Global Standards-Based Bar Code Technology Into National Health Information Systems in Ethiopia and Pakistan to Increase End-to-End Supply Chain Visibility.

Authors:  Liuichi Hara; Ramy Guirguis; Keith Hummel; Monica Villanueva
Journal:  Glob Health Sci Pract       Date:  2017-12-28

6.  Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study.

Authors:  Timothy Roberton; Emily D Carter; Victoria B Chou; Angela R Stegmuller; Bianca D Jackson; Yvonne Tam; Talata Sawadogo-Lewis; Neff Walker
Journal:  Lancet Glob Health       Date:  2020-05-12       Impact factor: 26.763

7.  COVID-19 in Oromia Region of Ethiopia: a review of the first 6 months' surveillance data.

Authors:  Esayas Kebede Gudina; Dabesa Gobena; Tessema Debela; Daniel Yilma; Tsinuel Girma; Zeleke Mekonnen; Mirkuzie Woldie; Dereje Abdena; Gemechu Shume; Birhanu Kenate; Meles Lemi; Dereje Diriba; Tizta Tilahun Degfie
Journal:  BMJ Open       Date:  2021-03-29       Impact factor: 2.692

8.  A sustainable-resilience healthcare network for handling COVID-19 pandemic.

Authors:  Fariba Goodarzian; Peiman Ghasemi; Angappa Gunasekaren; Ata Allah Taleizadeh; Ajith Abraham
Journal:  Ann Oper Res       Date:  2021-10-07       Impact factor: 4.820

9.  The Impact of COVID-19 on Essential Medicines and Personal Protective Equipment Availability and Prices in Saudi Arabia.

Authors:  Rana Aljadeed; Yazed AlRuthia; Bander Balkhi; Ibrahim Sales; Monira Alwhaibi; Omar Almohammed; Abdulaziz J Alotaibi; Ali M Alrumaih; Yousif Asiri
Journal:  Healthcare (Basel)       Date:  2021-03-07

10.  Impact of the COVID-19 Pandemic on Consumers' Access to Essential Medicines in Nigeria.

Authors:  Nwoke Emmanuel Awucha; Ofomata Chinelo Janefrances; Amadi Chima Meshach; Jibuaku Chiamaka Henrietta; Akahome Ibilolia Daniel; Nwagbo Esther Chidiebere
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

View more
  1 in total

1.  Availability and stock-out duration of essential medicines in Shegaw Motta general hospital and Motta Health Centre, North West Ethiopia.

Authors:  Bereket Bahiru Tefera; Chernet Tafere; Adane Yehualaw; Ephrem Mebratu; Yalelet Chanie; Simachew Ayele; Sewnet Adane
Journal:  PLoS One       Date:  2022-09-16       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.